| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...987843F |
| P356 | DOI | 10.1371/JOURNAL.PONE.0087843 |
| P932 | PMC publication ID | 3972180 |
| P698 | PubMed publication ID | 24691160 |
| P5875 | ResearchGate publication ID | 261292476 |
| P50 | author | Attila Tóth | Q42847679 |
| P2093 | author name string | Zoltán Papp | |
| István Édes | |||
| Andrea Daragó | |||
| Emese Bányai | |||
| Miklós Fagyas | |||
| Ivetta M Siket | |||
| Judit Boczán | |||
| Katalin Úri | |||
| P2860 | cites work | Properties and human origin of two angiotensin-I-converting enzyme inhibitory peptides isolated from a tryptic hydrolysate of human serum albumin | Q74086846 |
| Point mutation in the stalk of angiotensin-converting enzyme causes a dramatic increase in serum angiotensin-converting enzyme but no cardiovascular disease | Q74499654 | ||
| Acein-1, a novel angiotensin-I-converting enzyme inhibitory peptide isolated from tryptic hydrolysate of human plasma | Q77596534 | ||
| A continuous fluorescence resonance energy transfer angiotensin I-converting enzyme assay | Q80285964 | ||
| Joint societies CVD Prevention Guidelines launched in May 2012 | Q84510247 | ||
| An angiotensin-converting enzyme (ACE) inhibitor in human serum. Increased sensitivity of the serum ACE assay for detecting active sarcoidosis. | Q52620527 | ||
| Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. | Q52855193 | ||
| Ramipril lowered cardiovascular risk, but vitamin E did not | Q54152721 | ||
| Antioxidant, antibacterial and ACE-inhibitory activity of four monofloral honeys in relation to their chemical composition. | Q54303553 | ||
| ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and | Q56680457 | ||
| Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) | Q57245141 | ||
| Inhibition of angiotensin-converting enzyme by des-Leu10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme regulation | Q70136964 | ||
| Automated kinetic assay of angiotensin-converting enzyme in serum | Q70137199 | ||
| Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Mio | Q70890475 | ||
| C-type natriuretic peptide. An endogenous inhibitor of vascular angiotensin-converting enzyme activity | Q71129321 | ||
| Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies | Q71503825 | ||
| ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collabor | Q72028603 | ||
| Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy | Q72220327 | ||
| Isolation of angiotensin converting enzyme (ACE) binding protein from human serum with an ACE affinity column | Q73118013 | ||
| ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites | Q73435170 | ||
| Isolation of acein-2, a novel angiotensin-I-converting enzyme inhibitory peptide derived from a tryptic hydrolysate of human plasma | Q73450448 | ||
| ??? | Q22242895 | ||
| ??? | Q28267062 | ||
| A strategy to reduce cardiovascular disease by more than 80% | Q24679592 | ||
| Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE | Q28116521 | ||
| A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure | Q28328342 | ||
| The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data | Q30664916 | ||
| The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not. | Q33899337 | ||
| Guidelines on myocardial revascularization | Q34134730 | ||
| An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels | Q34262228 | ||
| Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). | Q34539439 | ||
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Preventing microalbuminuria in type 2 diabetes | Q34552302 | ||
| Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents | Q34936463 | ||
| New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases. | Q35137270 | ||
| New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human | Q35137588 | ||
| Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels | Q35196218 | ||
| ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? | Q36719942 | ||
| Mammalian inhibitors of angiotensin converting enzyme (kininase II) | Q40278426 | ||
| Inhibition of human peptidyl dipeptidase (angiotensin I converting enzyme: kininase II) by human serum albumin and its fragments | Q40298049 | ||
| Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. | Q40964402 | ||
| Endogenous inhibitor of angiotensin converting enzyme in the rat heart | Q44136255 | ||
| Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study. | Q44200597 | ||
| Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine alphaS2-casein | Q44205621 | ||
| ACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008. | Q44239004 | ||
| Inhibition of angiotensin converting enzyme by N-terminal fragments of substance P. | Q44594728 | ||
| The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League | Q46542420 | ||
| Observation of high and low molecular weight inhibitors of angiotensin-converting enzyme in rat lung | Q47331823 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e87843 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition | |
| P478 | volume | 9 |
| Q92511664 | Aliskiren, Fosinopril, and Their Outcome on Renin-Angiotensin-Aldosterone System (RAAS) in Rats with Thyroid Dysfunction |
| Q93376749 | Angiotensin Converting Enzyme Insertion/Deletion Polymorphism is Associated with Breast Cancer Risk: A Meta-Analysis |
| Q48396569 | Circulating ACE2 activity correlates with cardiovascular disease development. |
| Q40873689 | Isolation of an Angiotensin I-Converting Enzyme Inhibitory Protein with Antihypertensive Effect in Spontaneously Hypertensive Rats from the Edible Wild Mushroom Leucopaxillus tricolor |
| Q35137588 | New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human |
| Q35137270 | New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases. |
| Q28541744 | New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure |
| Q35818611 | Renal Effects and Underlying Molecular Mechanisms of Long-Term Salt Content Diets in Spontaneously Hypertensive Rats |
| Q97436055 | Tenascin-C aggravates ventricular dilatation and angiotensin-converting enzyme activity after myocardial infarction in mice |
| Q35850689 | Tissue Specificity of Human Angiotensin I-Converting Enzyme |
Search more.